Vic Velanovich
Experienced in Laryngectomy

Dr. Vic Velanovich

General Surgery
1 Tampa General Cir, 
Tampa, FL 
Accepting New Patients
Experienced in Laryngectomy
1 Tampa General Cir, 
Tampa, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vic Velanovich is a General Surgeon in Tampa, Florida. Dr. Velanovich is rated as an Experienced provider by MediFind in Laryngectomy. His top areas of expertise are Hiatal Hernia, Achalasia, Hernia, Endoscopy, and Hernia Surgery. Dr. Velanovich is currently accepting new patients.

His clinical research consists of co-authoring 130 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Laryngectomy.

Specialties
General Surgery
Licenses
Surgery in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

1 Tampa General Cir, Tampa, FL 33606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer
The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 05, 2025
Intervention Type: Other
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Staccato Granisetron (AZ-010) for the Acute Treatment of Moderate to Severe Cyclic Vomiting Syndrome
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Staccato Granisetron (AZ-010) for the Acute Treatment of Moderate to Severe Cyclic Vomiting Syndrome
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Combination product
Study Drug: AZ-010
Study Phase: Phase 2
A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife® System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife® System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2025
Intervention Type: Drug, Device
Study Drug: Modified FOLFIRINOX
Study Phase: Phase 3
Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2025
Intervention Type: Drug, Device
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3
Prospective, Observational Trial of Biological or Prosthetic Mesh for Open Ventral Hernia Repair
Prospective, Observational Trial of Biological or Prosthetic Mesh for Open Ventral Hernia Repair
Enrollment Status: Terminated
Publish Date: October 06, 2021
Intervention Type: Device
Randomized, Controlled Trial Comparing Separation of Components Repair With Retrorectus Gentrix™ Surgical Matrix Versus Biological or Prosthetic Mesh for Open Ventral Hernia Repair
Randomized, Controlled Trial Comparing Separation of Components Repair With Retrorectus Gentrix™ Surgical Matrix Versus Biological or Prosthetic Mesh for Open Ventral Hernia Repair
Enrollment Status: Terminated
Publish Date: September 29, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)
A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)
Enrollment Status: Terminated
Publish Date: October 18, 2019
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Comparison of Symptomatic and Radiographic Outcomes of Paraesophageal Hernia Repair With and Without MatriStem Surgical Matrix
Comparison of Symptomatic and Radiographic Outcomes of Paraesophageal Hernia Repair With and Without MatriStem Surgical Matrix
Enrollment Status: Completed
Publish Date: March 28, 2019
Intervention Type: Device
View 8 Less Clinical Trials

161 Total Publications

Tips for revisional antireflux surgery.
Tips for revisional antireflux surgery.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: May 22, 2025
Similar Doctors
Gary L. Clayman
Experienced in Laryngectomy
Dr. Gary L. Clayman
General Surgery | Otolaryngology
Experienced in Laryngectomy
Dr. Gary L. Clayman
General Surgery | Otolaryngology

Norman Clayman Endocrine Institute, LLC

5959 Webb Rd, 
Tampa, FL 
 (8.7 miles away)
813-940-3130
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Gary Clayman is a General Surgeon and an Otolaryngologist in Tampa, Florida. Dr. Clayman is rated as a Distinguished provider by MediFind in Laryngectomy. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Clayman is currently accepting new patients.

Experienced in Laryngectomy
Dr. Nathaniel J. Walsh
General Surgery | Otolaryngology
Experienced in Laryngectomy
Dr. Nathaniel J. Walsh
General Surgery | Otolaryngology

Norman Clayman Endocrine Institute, LLC

6001 Webb Rd, (hca Florida West Tampa), 
Tampa, FL 
 (8.3 miles away)
813-888-7060
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Nathaniel Walsh is a General Surgeon and an Otolaryngologist in Tampa, Florida. Dr. Walsh is rated as an Advanced provider by MediFind in Laryngectomy. His top areas of expertise are Medullary Thyroid Carcinoma, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Walsh is currently accepting new patients.

Experienced in Laryngectomy
Dr. Rashmi Roy
General Surgery
Experienced in Laryngectomy
Dr. Rashmi Roy
General Surgery

Norman Clayman Endocrine Institute, LLC

5959 Webb Rd, 
Tampa, FL 
 (8.7 miles away)
813-940-3130
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rashmi Roy is a General Surgeon in Tampa, Florida. Dr. Roy is rated as an Advanced provider by MediFind in Laryngectomy. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Roy is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Velanovich's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile